Publication Name	World Journal of Hepatology
Manuscript ID	90972
Country	Italy

Received	2023-12-26 23:10
Peer-Review Started	2023-12-26 23:10
To Make the First Decision
Return for Revision	2024-02-23 06:12
Revised	2024-03-06 22:16
Second Decision	2024-04-15 02:42
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-04-15 07:35
Articles in Press	2024-04-15 07:35
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-05-11 02:51
Publish the Manuscript Online	2024-05-22 11:33

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Editorial
Article Title	Hepatitis C virus eradication in people living with human immunodeficiency virus: Where are we now?
Manuscript Source	Invited Manuscript
All Author List	Anna Maria Spera, Pasquale Pagliano and Valeria Conti
ORCID	Author(s) ORCID Number Anna Maria Spera http://orcid.org/0000-0003-1292-3040 Valeria Conti http://orcid.org/0000-0001-6964-2739
Funding Agency and Grant Number
Corresponding Author	Anna Maria Spera, MD, PhD, Doctor, Postdoctoral Fellow, Infectious Disease Unit, Universitary Hospital OORR San Giovanni di Dio e Ruggi d'Aragona, Largo Ippocrate, Salerno 84131, Italy. annamariaspera@hotmail.it
Key Words	Hepatitis; People living with human immunodeficiency virus; Direct acting antivirals; Highly active antiretroviral therapy; Co-infection
Core Tip	Considering the quite high prevalence of hepatitis C virus (HCV) co-infection in people living with human immunodeficiency virus (PLWH), along with the interplay of HCV and human immunodeficiency virus infections, the usefulness of direct acting antivirals (DAAs) therapy regimen for the cure of HCV in this context appears crucial. However, apart from several known drug-drug interactions between highly active antiretroviral therapy (HAART) and DAAs, the metabolic impact of HCV eradication in terms of worsening of lipid profile as well as the improvement of glucose metabolism must be taken into account. The treatment of HCV infection in PLWH under HAART represents a challenge as well as a great opportunity for clinicians and deserves attention.
Publish Date	2024-05-22 11:33
Citation	<p>Spera AM, Pagliano P, Conti V. Hepatitis C virus eradication in people living with human immunodeficiency virus: Where are we now? <i>World J Hepatol</i> 2024; 16(5): 661-666</p>
URL	https://www.wjgnet.com/1948-5182/full/v16/i5/661.htm
DOI	https://dx.doi.org/10.4254/wjh.v16.i5.661

Full Article (PDF)	WJH-16-661-with-cover.pdf
Manuscript File	90972_Auto_Edited-YJP.docx
Answering Reviewers	90972-Answering reviewers.pdf
Audio Core Tip	90972-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	90972-Conflict-of-interest statement.pdf
Copyright License Agreement	90972-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	90972-Language certificate.pdf
Peer-review Report	90972-Peer-review(s).pdf
Scientific Misconduct Check	90972-CrossCheck.png
Scientific Misconduct Check	90972-Bing-Gong ZM-2.png
Scientific Editor Work List	90972-Scientific editor work list.pdf
CrossCheck Report	90972-CrossCheck report.pdf